Loss of p21WAF1/CIP1 expression correlates with disease progression in gastric carcinoma.

por Ogawa, M., Maeda, K., Onoda, N., Chung, Y. S., Sowa, M.
Publicado 1997

Efficacy of epidermal growth factor receptor-targeted molecular therapy in anaplastic thyroid cancer cell lines

por Nobuhara, Y, Onoda, N, Yamashita, Y, Yamasaki, M, Ogisawa, K, Takashima, T, Ishikawa, T, Hirakawa, K
Publicado 2005

Tumour angiogenesis and tumour cell proliferation as prognostic indicators in gastric carcinoma.

por Maeda, K., Chung, Y. S., Takatsuka, S., Ogawa, Y., Onoda, N., Sawada, T., Kato, Y., Nitta, A., Arimoto, Y., Kondo, Y.
Publicado 1995

Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma.

por Maeda, K., Chung, Y. S., Ogawa, Y., Takatsuka, S., Kang, S. M., Ogawa, M., Sawada, T., Onoda, N., Kato, Y., Sowa, M.
Publicado 1996

Inhibition of human pancreatic cancer cell (MIA PaCa-2) growth by cholera toxin and 8-chloro-cAMP in vitro.

por Ohmura, E., Wakai, K., Isozaki, O., Murakami, H., Onoda, N., Emoto, N., Shizume, K., Tsushima, T., Demura, H., Robins, R. K.
Publicado 1993

Serum soluble interleukin-2 receptor level as a prognostic indicator in gastric cancer.

por Nakata, B., Chung, K. H., Kato, Y., Yamashita, Y., Inui, A., Arimoto, Y., Maeda, K., Onoda, N., Sawada, T., Sowa, M.
Publicado 1998